Interestingly, EZH2 inhibitor GSK126 was able to reverse the suppression of Runx2 and osteoblast differentiation of MC4 cells and human MM patient bone marrow stem cells induced by exposure to MM cells. Here, RUNX2 is linked to Miyoshi myopathy.